0001104659-17-048996.txt : 20170802
0001104659-17-048996.hdr.sgml : 20170802
20170802183034
ACCESSION NUMBER: 0001104659-17-048996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170731
FILED AS OF DATE: 20170802
DATE AS OF CHANGE: 20170802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bourdow Carrie L.
CENTRAL INDEX KEY: 0001638989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 171001608
MAIL ADDRESS:
STREET 1: C/O TREVENA, INC.
STREET 2: 1018 WEST 8TH AVENUE, SUITE A
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
a4.xml
4
X0306
4
2017-07-31
0
0001641640
Nabriva Therapeutics plc
NBRV
0001638989
Bourdow Carrie L.
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
Director
Stock Option
2017-07-31
4
A
0
20200
0.00
A
2027-07-31
Ordinary Shares
20200
20200
D
The exercise price is Euro 8.94 per share.
This option was granted on July 31, 2017. Vesting began on July 31, 2017 and ends on July 31, 2020. This option vests on a monthly pro-rata basis at the end of each successive month following July 31, 2017.
/s/ Robert Crotty, by power of attorney
2017-08-02